Multiple Sclerosis Treatment
- Home
- /
- Treatments
- /
- Neurological diseases
- /
- Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune disorder that disrupts communication between the brain and the rest of the body. It affects millions of people globally, with a growing number of cases emerging in India. While conventional treatments often focus on suppressing inflammation and slowing disease progression, they do little to repair the damage already done to the nervous system.
At AMS Asia, we help patients and their care providers explore regenerative strategies for MS that go beyond managing symptoms. Through our network of expert partners in Southeast Asia, we coordinate access to mesenchymal stem cell (MSC) therapy, exosome therapy, and comprehensive support programs designed to preserve neurological function and improve quality of life.
Multiple sclerosis occurs when the immune system mistakenly attacks the myelin sheath—the protective layer surrounding nerve fibers—leading to communication disruptions between the brain, spinal cord, and body. The disease presents in various forms and can cause a wide range of symptoms, including:
Persistent fatigue
Muscle stiffness and spasms
Numbness, tingling, or weakness in limbs
Visual disturbances
Difficulty with balance and coordination
In India, MS is often underdiagnosed, and treatment is typically delayed. Many patients struggle with:
Unpredictable relapses that lead to increasing disability
Limited response to immunosuppressive drugs
Accumulated nerve damage that conventional therapies cannot reverse
Coexisting issues such as hormonal imbalances, gut dysfunction, and mitochondrial stress
Early intervention is key to minimizing long-term damage and maintaining function.
AMS Asia connects patients with trusted providers offering regenerative therapies that aim to repair damage and regulate immune responses—addressing the root biological drivers of MS, not just its symptoms.
MSCs are multipotent cells that help regulate the immune system, reduce inflammation, and promote tissue repair. Their benefits in MS include:
Calming immune overactivity by reducing harmful T-cell activity and enhancing regulatory T-cell balance
Modulating microglial activation to reduce inflammation in the brain and spinal cord
Supporting remyelination and neuronal survival
Secreting neurotrophic factors such as BDNF and NGF to aid in nerve regeneration
Exosomes are nano-sized vesicles derived from MSCs that deliver molecular signals directly into target tissues. They can cross the blood-brain barrier and support cellular repair in a less invasive, cell-free format. Key benefits include:
Delivery of microRNAs and proteins that regulate immune function
Reduction of inflammatory mediators such as IL-6 and TNF-α
Promotion of myelin regeneration and axonal repair
Enhancement of synaptic plasticity and neurological resilience
Exosome therapy is particularly suitable for patients in early or stable stages, and for those who prefer non-cell-based treatments.
Effective MS care begins with identifying the biological factors that drive disease activity. AMS Asia helps patients access in-depth diagnostic assessments that form the foundation of each individualized treatment plan.
Immune system mapping, including Th1/Th17 imbalances and cytokine panels
Mitochondrial function and oxidative stress testing
Hormonal profiling, including thyroid, adrenal, and sex hormones
MRI and imaging reviews for lesion tracking and brain volume assessment
Gut-brain axis analysis, microbiome status, and intestinal permeability
Environmental toxin and heavy metal screening
Viral reactivation testing (e.g., EBV, CMV)
These insights are used to design precise, data-informed regenerative care strategies.
To enhance outcomes, AMS Asia coordinates access to a wide range of adjunctive therapies. These treatments are tailored to the individual and designed to support immune regulation, neurological recovery, and systemic balance.
Supportive therapies may include:
IV nutrient therapy: glutathione, NAD+, B-complex vitamins, and magnesium to aid cellular repair
Peptide therapy: agents like thymosin alpha-1, BPC-157, and cerebrolysin to support neuroregeneration
Bioidentical hormone optimization: to stabilize metabolic and neurological systems
Gut repair protocols: including probiotics, anti-inflammatory nutrients, and mucosal support
Neurorehabilitation and physiotherapy: movement-based approaches to improve coordination and strength
Mind-body support: including stress reduction strategies to help regulate immune activity
This combination addresses a full spectrum of MS-related symptoms, from fatigue and flares to neurodegeneration and mood instability.
Indian patients turn to AMS Asia for coordinated access to world-class regenerative care. We are not a hospital or treatment center. Our role is to help patients make informed decisions, access advanced diagnostics, and connect with trusted regenerative medicine partners across Southeast Asia.
Our network includes internationally accredited clinics, trained specialists, and programs based on the latest research. For Indian medical tourism facilitators and neurology practices, partnering with AMS Asia offers a valuable opportunity to deliver next-generation solutions to MS patients without the need for in-house infrastructure.
Multiple sclerosis doesn’t have to mean inevitable decline. With the right regenerative strategy, it is possible to reduce flare-ups, slow progression, and restore function.
Contact AMS Asia today to explore how we can help design a personalized multiple sclerosis care pathway, combining cutting-edge therapies with compassionate support—all tailored to your biology and goals.